Nanomedicine News RSS Feed - Nanomedicine

Enhanced Red-Emission Nanoparticles Combined with Photodynamic Drug Therapy Kills Malignant Cells

Enhanced Red-Emission Nanoparticles Combined with Photodynamic Drug Therapy Kills Malignant Cells

An international group of scientists led by Gang Han, PhD, has combined a new type of nanoparticle with an FDA-approved photodynamic therapy to effectively kill deep-set cancer cells in vivo with minimal damage to surrounding tissue and fewer side effects than chemotherapy. This promising new treatment strategy could expand the current use of photodynamic therapies to access deep-set cancer tumors. [More]
Nano-Optics Researchers Develop Light-Based Sensor for Blood Analysis

Nano-Optics Researchers Develop Light-Based Sensor for Blood Analysis

The development is based on optical principles and provides precision and allows saving vital time for the patient. [More]
UCI Receives NSF Grant to Further Develop Nano-Optical Sensor for Detecting Infection in Breath

UCI Receives NSF Grant to Further Develop Nano-Optical Sensor for Detecting Infection in Breath

Imagine a low-cost, disposable breath analysis device that a person with cystic fibrosis could use at home along with a smartphone to immediately detect a lung infection, much like the device police use to gauge a driver's blood alcohol level. [More]
Alnylam Presents Clinical Data for Patisiran Phase II OLE Study for Familial Amyloidotic Polyneuropathy

Alnylam Presents Clinical Data for Patisiran Phase II OLE Study for Familial Amyloidotic Polyneuropathy

Tekmira Pharmaceuticals Corporation, a leading developer of RNA interference (RNAi) therapeutics, today reported that Alnylam Pharmaceuticals, Inc. presented six-month clinical data for the ongoing Patisiran Phase II Open Label Extension (OLE) study in patients with Familial Amyloidotic Polyneuropathy (FAP). [More]
Nanosphere Receives FDA 510(k) Clearance for Verigene Enteric Pathogens Nucleic Acid Test

Nanosphere Receives FDA 510(k) Clearance for Verigene Enteric Pathogens Nucleic Acid Test

Nanosphere, Inc., a company enhancing medicine through targeted molecular diagnostics, today announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Verigene® Enteric Pathogens Nucleic Acid Test (EP), which now includes additional viral targets, as well as the bacterial and toxigenic targets cleared by FDA earlier this summer. [More]
Nanoscale DNA Cocoons Target Cancer Cells

Nanoscale DNA Cocoons Target Cancer Cells

Biomedical engineering researchers have developed a drug delivery system consisting of nanoscale “cocoons” made of DNA that target cancer cells and trick the cells into absorbing the cocoon before unleashing anticancer drugs. The work was done by researchers at North Carolina State University and the University of North Carolina at Chapel Hill. [More]
Onxeo Receives Second Payment from BPIFrance for Support of Nano Innovation for Cancer Consortium

Onxeo Receives Second Payment from BPIFrance for Support of Nano Innovation for Cancer Consortium

Onxeo S.A. (Euronext Paris, NASDAQ OMX Copenhagen: ONXEO), an innovative biopharmaceutical company specialized in the development of orphan oncology drugs, today announces the second payment of €1.25 million from BPIFrance (ex OSEO) as a part of the funding granted to support the NICE (Nano Innovation for Cancer) consortium. [More]
Scientists Identify Key Characteristics That Enhance Nanoparticle’s Ability to Penetrate Skin

Scientists Identify Key Characteristics That Enhance Nanoparticle’s Ability to Penetrate Skin

Scientists at the University of Southampton have identified key characteristics that enhance a nanoparticle's ability to penetrate skin, in a milestone study which could have major implications for the delivery of drugs. [More]
Aciex Awarded US Patent for Novel Nanocrystalline Formulations of Fluticasone Propionate

Aciex Awarded US Patent for Novel Nanocrystalline Formulations of Fluticasone Propionate

Aciex Therapeutics, Inc. today announced that the United States Patent and Trademark Office (USPTO) has issued a U.S. Patent (No. 8,829,005) covering AC-170 Cetirizine Ophthalmic Compositions and a U.S. Patent (No. 8,765,725) covering AC-155 Fluticasone Propionate Nano-crystalline Compositions. [More]
MJR PharmJet Wins Award for Technology That Enables Increased Drug Loading of Hydrophobic Nanoparticles

MJR PharmJet Wins Award for Technology That Enables Increased Drug Loading of Hydrophobic Nanoparticles

CPhI Worldwide, organised by UBM Live, announced the winners of the 11th annual CPhI live Pharma Awards. The annual awards showcase outstanding developments and innovations from the pharma industry's most dynamic and progressive players. [More]